Biopharmaceutical Research Company

Cancer treatment and research center City of Hope and Biopharmaceutical Research Company, a pharmaceutical company that specializes in the development of proprietary cannabinoid therapeutics, announced on Thursday that the first patient has received BRC-001, an experimental supportive care therapy...

In a pivotal moment for the American cannabis sector, the U.S. Department of Health and Human Services (HHS) has proposed a reclassification of cannabis to the DEA. This could shift cannabis from its current Schedule I status, bringing potential upheaval in the perception and market dynamics of the...

The Biopharmaceutical Research Company (BRC), an active DEA pharmaceutical cannabis license holder, announced the completion of a $20 million Series A fundraise, that will enable the company to scale its operations and increase its product offering, conduct sponsored research, and execute...

Open Book Extracts (OBX) entered into a partnership with Biopharmaceutical Research Company (BRC). Under the terms of the collaboration, OBX will leverage BRC's research platforms, in order to develop research-backed formulations and products including Delta-9 THC. From preclinical and first-in...

The Drug Enforcement Administration (DEA) finally authorized two cannabis companies to harvest marijuana for research purposes, reported Marijuana Moment, ending a five-decade federal monopoly. Why is this important?  Because a farm functioning as part of the ...